Matches in Wikidata for { <http://www.wikidata.org/entity/Q86085482> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q86085482 description "article scientifique publié en 2017" @default.
- Q86085482 description "artículu científicu espublizáu n'agostu de 2017" @default.
- Q86085482 description "scientific article published on 01 August 2017" @default.
- Q86085482 description "wetenschappelijk artikel" @default.
- Q86085482 description "наукова стаття, опублікована в серпні 2017" @default.
- Q86085482 name "High-risk Prostate Cancer Treated With Dose-escalated RT: An Analysis of Hormonal Therapy Use and Duration, and Prognostic Implications of PSA Nadir ≤0.2 to Select Men for Short-term Hormonal Therapy" @default.
- Q86085482 name "High-risk Prostate Cancer Treated With Dose-escalated RT: An Analysis of Hormonal Therapy Use and Duration, and Prognostic Implications of PSA Nadir ≤0.2 to Select Men for Short-term Hormonal Therapy" @default.
- Q86085482 type Item @default.
- Q86085482 label "High-risk Prostate Cancer Treated With Dose-escalated RT: An Analysis of Hormonal Therapy Use and Duration, and Prognostic Implications of PSA Nadir ≤0.2 to Select Men for Short-term Hormonal Therapy" @default.
- Q86085482 label "High-risk Prostate Cancer Treated With Dose-escalated RT: An Analysis of Hormonal Therapy Use and Duration, and Prognostic Implications of PSA Nadir ≤0.2 to Select Men for Short-term Hormonal Therapy" @default.
- Q86085482 prefLabel "High-risk Prostate Cancer Treated With Dose-escalated RT: An Analysis of Hormonal Therapy Use and Duration, and Prognostic Implications of PSA Nadir ≤0.2 to Select Men for Short-term Hormonal Therapy" @default.
- Q86085482 prefLabel "High-risk Prostate Cancer Treated With Dose-escalated RT: An Analysis of Hormonal Therapy Use and Duration, and Prognostic Implications of PSA Nadir ≤0.2 to Select Men for Short-term Hormonal Therapy" @default.
- Q86085482 P1433 Q86085482-CBA7532E-93CE-493F-BCB2-53413AAC798F @default.
- Q86085482 P1476 Q86085482-B317EC3F-7C4E-4D19-BF12-E647909866FB @default.
- Q86085482 P2093 Q86085482-3C19B9F1-0FE6-4CB0-8F1D-447824B15529 @default.
- Q86085482 P2093 Q86085482-478689AE-EA74-4631-865B-2B492AFA8B31 @default.
- Q86085482 P2093 Q86085482-5FEBE80F-10F4-4FC7-A763-13CCF5159FB2 @default.
- Q86085482 P2093 Q86085482-A87F82C7-649D-4B35-A555-69E680108307 @default.
- Q86085482 P304 Q86085482-249A00E4-34F5-4996-9E85-FEB54CD3631A @default.
- Q86085482 P31 Q86085482-CA76FFF0-65E4-4813-B57F-C8D539B8776E @default.
- Q86085482 P356 Q86085482-5C6CB725-F3BE-4D24-85A7-EFE02B5F1E4B @default.
- Q86085482 P433 Q86085482-9101EA52-064A-4748-ADFE-A55724E9A1FA @default.
- Q86085482 P478 Q86085482-B2CE1B51-2075-451F-A33B-6ACADC86B7F0 @default.
- Q86085482 P577 Q86085482-27B62EDB-EA6E-456C-ACD9-59AE930E7A24 @default.
- Q86085482 P698 Q86085482-469EFCB5-E3BE-4FEF-8734-DB6D7B44C6DF @default.
- Q86085482 P356 COC.0000000000000161 @default.
- Q86085482 P698 25436827 @default.
- Q86085482 P1433 Q2886177 @default.
- Q86085482 P1476 "High-risk Prostate Cancer Treated With Dose-escalated RT: An Analysis of Hormonal Therapy Use and Duration, and Prognostic Implications of PSA Nadir ≤0.2 to Select Men for Short-term Hormonal Therapy" @default.
- Q86085482 P2093 "Christina H Son" @default.
- Q86085482 P2093 "Daniel A Hamstra" @default.
- Q86085482 P2093 "Felix Y Feng" @default.
- Q86085482 P2093 "Stanley L Liauw" @default.
- Q86085482 P304 "348-352" @default.
- Q86085482 P31 Q13442814 @default.
- Q86085482 P356 "10.1097/COC.0000000000000161" @default.
- Q86085482 P433 "4" @default.
- Q86085482 P478 "40" @default.
- Q86085482 P577 "2017-08-01T00:00:00Z" @default.
- Q86085482 P698 "25436827" @default.